mifepristone has been researched along with cyclin d1 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musgrove, EA; Sutherland, RL | 1 |
| Cornish, AL; Lee, CS; Musgrove, EA; Sutherland, RL; Swarbrick, A | 1 |
| Fernandes, D; Guida, E; Harris, T; Koutsoubos, V; Stewart, AG; Vadiveloo, P; Wilson, JW | 1 |
| Agarwal, R; Bhatia, N; Jiang, W; Thompson, HJ; Zhu, Z | 1 |
| Faivre, E; Lange, CA; Skildum, A | 1 |
| Hienola, A; Korhonen, L; Lindholm, D; Savola, S; Sundberg, M | 1 |
| Cheng, C; Huang, X; Liu, H; Shen, A; Wang, H | 1 |
| Camacho-Arroyo, I; González-García, TK; Hernández-Hernández, OT | 1 |
| Giulianelli, S; Gorostiaga, MA; Jacobsen, B; Lanari, C; May, M; Molinolo, A; Novaro, V; Polo, ML; Riggio, M; Rojas, P; Sequeira, GR; Wargon, V | 1 |
| Błaszczak-Świątkiewicz, K | 1 |
10 other study(ies) available for mifepristone and cyclin d1
| Article | Year |
|---|---|
Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes.
Topics: Breast Neoplasms; Cell Cycle; Cyclin D1; Cyclins; Dose-Response Relationship, Drug; Estradiol; Humans; Mifepristone; Oncogene Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone Congeners; Progestins; Proto-Oncogene Proteins c-myc; RNA, Messenger; S Phase; Tumor Cells, Cultured | 1993 |
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance; Estrenes; Furans; Hormone Antagonists; Humans; Mifepristone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogene Proteins; Phosphorylation; Progestins; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Retinoblastoma Protein; Tumor Cells, Cultured | 1997 |
Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle.
Topics: Androstadienes; Bronchi; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; Cell Division; Cells, Cultured; Cyclin D1; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Fluticasone; Glucocorticoids; Humans; Inhibitory Concentration 50; MAP Kinase Kinase 1; Mifepristone; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Retinoblastoma Protein; Thrombin | 1999 |
Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis.
Topics: Animals; Cell Cycle; Cell Cycle Proteins; Cell Division; Corticosterone; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Energy Intake; Hyperplasia; Insulin-Like Growth Factor I; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mifepristone; Proto-Oncogene Proteins; Tumor Suppressor Proteins | 2002 |
Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Topics: Binding Sites; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media, Serum-Free; Cyclin D1; Disease Progression; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Ligands; Luciferases; MAP Kinase Signaling System; Mifepristone; Phosphorylation; Point Mutation; Progestins; Receptors, Progesterone; S Phase; Serine; Time Factors; Transcription, Genetic; Transcriptional Activation; Up-Regulation | 2005 |
Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1.
Topics: Animals; Brain; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclin D1; Dexamethasone; Glucocorticoids; Hormone Antagonists; Lateral Ventricles; Leupeptins; Male; Mifepristone; Neurons; Pluripotent Stem Cells; Rats; Rats, Wistar; Receptors, Glucocorticoid; Ubiquitins; Up-Regulation | 2006 |
Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line.
Topics: A Kinase Anchor Proteins; Actins; Animals; Antineoplastic Agents, Hormonal; Cell Cycle Proteins; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cyclin D1; Cytoskeleton; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression; Mifepristone; Mitogen-Activated Protein Kinase 1; Phosphorylation; Protein Transport; Rats; Receptors, Glucocorticoid; RNA, Messenger; Time | 2009 |
Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines.
Topics: Astrocytoma; Cell Line, Tumor; Cyclin D1; ErbB Receptors; Gene Knockdown Techniques; Hormone Antagonists; Humans; Mifepristone; Nuclear Receptor Coactivator 1; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger; Vascular Endothelial Growth Factor A | 2012 |
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Nuclear Receptor Co-Repressor 2; Nuclear Receptor Coactivator 3; Progestins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Receptors, Progesterone | 2015 |
New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Mifepristone; NF-kappa B; Progesterone; Progestins; Protein Stability; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Progesterone | 2020 |